Evidence map›Paper›PMID 28831830›Full record

ReviewActa orthopaedica2017

Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates.

Gilbert Moatshe, Elizabeth R Morris, Mark E Cinque, Cecilia Pascual-Garrido, Jorge Chahla, Lars Engebretsen, Robert F Laprade

Registry-linked trialAbstract readReview
In one paragraph

Review in Acta orthopaedica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04711551 (Patients-reported Outcome Measures), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04711551 recruitingnot on this mapstarted 2018, after this paper: background citation

Patients-reported Outcome Measures (PROMs), Clinical Objective and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

TypeobservationalSponsorI.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRan2018 to 2030Enrolled2,000ConditionsMusculoskeletal System DiseaseArmsPRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Anterior Knee Pain: State of the Art.Sports medicine - open · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Platelet-rich plasmaWorld journal of stem cells · 2021
    Review
  8. The platelet-rich plasma and mesenchymal stem cell milieu: A review of therapeutic effects on bone healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Review
  9. Article
  10. Cell Therapy-a Basic Science Primer for the Sports Medicine Clinician.Current reviews in musculoskeletal medicine · 2019
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Patellofemoral Cartilage Repair.Current reviews in musculoskeletal medicine · 2018
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gilbert Moatshea Oslo University Hospital and University of Oslo , Oslo , Norway.
Elizabeth R Morrisb Steadman Philippon Research Institute , Vail , CO , USA.
Mark E Cinqueb Steadman Philippon Research Institute , Vail , CO , USA.
Cecilia Pascual-Garridoe Washington University Orthopaedics , St. Louis , MO , USA.
Jorge Chahlab Steadman Philippon Research Institute , Vail , CO , USA.
Lars Engebretsena Oslo University Hospital and University of Oslo , Oslo , Norway.
Robert F Lapradeb Steadman Philippon Research Institute , Vail , CO , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

- Knee pathologies including focal cartilage injuries, osteoarthritis (OA), and ligament injuries are common. The poor regeneration and healing potential of cartilage has led to the search for other treatment modalities with improved healing capacity. Furthermore, with an increasing elderly population that desires to remain active, the burden of knee pathologies is expected to increase. Increased sports participation and the desire to return to activities faster is also demanding more effective and minimally invasive treatment options. Thus, the use of biologic agents in the treatment of knee pathologies has emerged as a potential option. Despite the increasing use of biologic agents for knee pathology, there are conflicting results on the efficacy of these products. Furthermore, strong data supporting the optimal preparation methods and composition for widely used biologic agents, such as platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC), largely remain absent from the literature. This review presents the literature on the most commonly employed biologic agents for the different knee pathologies.

Indexed as

Bone Marrow CellsPlatelet-Rich PlasmaBiological TherapyHumansInjectionsKnee JointOsteoarthritis, Knee

Identifiers

PMID28831830
PMCPMC5694813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.